Skip to main content
. Author manuscript; available in PMC: 2018 Feb 1.
Published in final edited form as: Acta Biomater. 2016 Dec 1;49:507–520. doi: 10.1016/j.actbio.2016.11.071

Fig. 8. Assessments of Si-CFEu and USPIO nanoparticle biodistribution by MRI tests.

Fig. 8

(A) The time line of the experimental procedure is shown (LPS: Lipopolysaccharide, 5 mg/kg; MRI: magnetic resonance imaging scaning: NP: Nanoparticles). The representative T2 maps of magnetic resonance (MR) images of rats (B) with pre-(left) and 24 hours after (right) 1 mg iron/kg IV administration of USPIO nanoparticle and (C) Si-CFEu nanoparticles, respectively (red: liver and green:spleen).